Suramin for prostatic cancer: a phase I/II study in advanced extensively pretreated disease.
Van Oosterom
A T
AT
Department of Oncology, Antwerp University Hospital, Edegem, Belgium.
De Smedt
E A
EA
Denis
L J
LJ
de Bruijn
E A
EA
Mahler
C
C
D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*; D012074:Remission Induction; D013498:Suramin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*
D013498:Suramin